26 results
8-K
EX-99.1
TSHA
Taysha Gene Therapies Inc
19 Mar 24
Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates
4:17pm
Highlights
Strengthened clinical and regulatory leadership with the promotion of Meredith Schultz, M.D., M.S., to Chief Medical Officer and Rumana Haque-Ahmed
PRE 14A
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Preliminary proxy
4:03pm
THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Independence of the Board of Directors
Board Leadership Structure
Role of the Board in Risk Oversight … on his role as our Chief Executive Officer and his more than 30 years of broad leadership and management experience in the biopharmaceutical industry
8-K
EX-99.1
8extg0 878rm
22 Dec 22
Taysha Gene Therapies Announces Executive Leadership Changes
4:08pm
8-K
qx4b2ixdgdw u8o89g
22 Dec 22
Taysha Gene Therapies Announces Executive Leadership Changes
4:08pm
8-K
EX-99.1
p68md19gdekd4jd
31 Jan 22
Other Events
7:16am
8-K
EX-99.1
1xej9an3no ou
16 Aug 21
Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
7:16am
DEF 14A
yimct6kuanaewpaxoodt
29 Apr 21
Definitive proxy
5:03pm
8-K
EX-99.1
i6ki26tl6o a4807p
14 Apr 21
Regulation FD Disclosure
4:20pm
10-K
pt4o12kyvjmbn4jl9p8g
3 Mar 21
Annual report
9:00am
8-K
EX-99.1
4mt4w13q1pg47tr dwbc
3 Mar 21
Taysha Gene Therapies Reports Full-Year 2020 Financial Results and Provides a Corporate Update
7:15am
8-K
EX-99.1
segnlu g7eos247n
1 Feb 21
Taysha Gene Therapies Highlights Strategic Priorities and Provides 2021 Business Outlook
7:15am
8-K
EX-99.1
ewn12 brvb
17 Dec 20
Taysha Gene Therapies Announces New cGMP Gene Therapy Manufacturing Facility
4:16pm
8-K
EX-99.1
5bfhc9n6y463xmbw
24 Nov 20
Taysha Gene Therapies Adds Industry-Leading Gene Therapy Executives to Board of Directors
7:15am
10-Q
d0dkurgoe rpx7n0oa
12 Nov 20
Quarterly report
4:27pm